A novel differentiation pathway from CD4⁺ T cells to CD4⁻ T cells for maintaining immune system homeostasis.-论文-万方医学网

第一作者： X,Zhao

第一单位： Experimental and Translational Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.;Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.;Beijing Key Laboratory of Tolerance Induction and Organ Protection in Transplantation, Beijing, China.;Beijing Key Laboratory of Translational Medicine in Liver Cirrhosis, Beijing, China.

作者： X,Zhao ^[1] ; G,Sun ^[2] ; X,Sun ^[2] ; D,Tian ^[2] ; K,Liu ^[2] ; T,Liu ^[3] ; M,Cong ^[4] ; H,Xu ^[2] ; X,Li ^[2] ; W,Shi ^[2] ; Y,Tian ^[2] ; J,Yao ^[5] ; H,Guo ^[6] ; D,Zhang ^[7]

作者单位： Experimental and Translational Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.;Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.;Beijing Key Laboratory of Tolerance Induction and Organ Protection in Transplantation, Beijing, China.;Beijing Key Laboratory of Translational Medicine in Liver Cirrhosis, Beijing, China. ^[1] Experimental and Translational Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.;Beijing Key Laboratory of Tolerance Induction and Organ Protection in Transplantation, Beijing, China. ^[2] Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.;Beijing Key Laboratory of Tolerance Induction and Organ Protection in Transplantation, Beijing, China.;Beijing Key Laboratory of Translational Medicine in Liver Cirrhosis, Beijing, China. ^[3] Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.;Beijing Key Laboratory of Translational Medicine in Liver Cirrhosis, Beijing, China.;National Clinical Research Center for Digestive Diseases, Beijing, China. ^[4] Experimental and Translational Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.;Beijing Key Laboratory of Tolerance Induction and Organ Protection in Transplantation, Beijing, China.;National Clinical Research Center for Digestive Diseases, Beijing, China. ^[5] Beijing Key Laboratory of Tolerance Induction and Organ Protection in Transplantation, Beijing, China. ^[6] Experimental and Translational Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.;Beijing Key Laboratory of Tolerance Induction and Organ Protection in Transplantation, Beijing, China.;Beijing Key Laboratory of Translational Medicine in Liver Cirrhosis, Beijing, China.;National Clinical Research Center for Digestive Diseases, Beijing, China. ^[7]

医学主题词动物(Animals);CD4阳性T淋巴细胞(CD4-Positive T-Lymphocytes);细胞分化(Cell Differentiation);细胞运动(Cell Movement);趋化因子CXCL10(Chemokine CXCL10);趋化因子CXCL9(Chemokine CXCL9);伴刀豆球蛋白A(Concanavalin A);细胞因子类(Cytokines);颗粒酶类(Granzymes);男(雄)性(Male);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);小鼠, 基因敲除(Mice, Knockout);OX40配体(OX40 Ligand);穿孔素(Perforin);RNA, 信使(RNA, Messenger);受体, CXCR3(Receptors, CXCR3);重组融合蛋白质类(Recombinant Fusion Proteins);T淋巴细胞(T-Lymphocytes);T淋巴细胞, 调节性(T-Lymphocytes, Regulatory)

DOI 10.1038/cddis.2016.83

PMID 27077809

发布时间 2018-11-13

检索历史清除

A novel differentiation pathway from CD4⁺ T cells to CD4⁻ T cells for maintaining immune system homeostasis.

Cell death & disease

相似文献

同项目论文

Cell death & disease

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A novel differentiation pathway from CD4⁺ T cells to CD4⁻ T cells for maintaining immune system homeostasis.

Cell death & disease

相似文献

同项目论文

Cell death & disease

相关期刊

检索历史清除